Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

IrelandBack to Ireland

Clinical trials in Drogheda – page 23

324 clinical trials in Drogheda, Ireland. Every trial is listed in the EU Clinical Trials Register and updated daily.

Drogheda at a glance
324
clinical trials
  • Research sites0
Type of trial
Recruitment status
Quick filters

324 trials in Drogheda

Open in trial search

Chronic lymphocytic leukaemia

Not recruiting

Study Comparing Pirtobrutinib with Idelalisib and Rituximab or Bendamustine and Rituximab for Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Registered drugNo placebo
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:Idelalisib
  • Sponsor:Loxo Oncology Inc.

Asthma

Not recruiting

Study on the Long-term Effects of Dupilumab in Preventing Lung Function Decline in Adults with Uncontrolled Moderate to Severe Asthma

Investigational
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:Dupilumab
  • Sponsor:Sanofi-Aventis Recherche & Developpement

Duchenne muscular dystrophy

Not recruiting

Study of DYNE-251 safety and effectiveness in patients with Duchenne muscular dystrophy who are candidates for exon 51 skipping treatment

Investigational
Countries:IrelandIreland
  • Participants:0–17 years
  • Sponsor:Dyne Therapeutics Inc.

HER2 positive breast cancer

Not recruiting

Study Comparing Trastuzumab Deruxtecan and Trastuzumab Emtansine for Patients with High-Risk HER2-Positive Breast Cancer with Residual Disease After Initial Treatment

Registered drugNo placebo
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:Trastuzumab Deruxtecan
  • Sponsor:Daiichi Sankyo Inc.

Breast cancer

Not recruiting

Study on Alpelisib and Fulvestrant for Men and Postmenopausal Women with Advanced HR-positive, HER2-negative Breast Cancer with PIK3CA Mutation

Registered drug
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:Alpelisib
  • Sponsor:Novartis Pharma AG

Prostate cancer metastatic

Not recruiting

Study of enzalutamide alone versus enzalutamide with radium-223 combination in patients with bone metastatic castration-resistant prostate cancer with mild or no symptoms

Registered drugNo placebo
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:Enzalutamide
  • Sponsor:European Organisation For Research And Treatment Of Cancer

Non-small cell lung cancer

Not recruiting

Study Comparing Adagrasib and Docetaxel for Patients with Advanced Non-Small Cell Lung Cancer with KRAS G12C Mutation

Registered drugNo placebo
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:Adagrasib
  • Sponsor:Mirati Therapeutics Inc.

Breast cancer+1

Not recruiting

Study of ribociclib combined with hormone therapy for patients with early-stage hormone receptor-positive, HER2-negative breast cancer

Registered drugNo placebo
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:Anastrozole
  • Sponsor:Novartis Pharma AG

Open angle glaucoma

Not recruiting

Study on the Effectiveness of Bimatoprost SR for Patients with Open-Angle Glaucoma or Ocular Hypertension

InvestigationalNo placebo
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:Bimatoprost
  • Sponsor:AbbVie Deutschland GmbH & Co. KG

Chronic lymphocytic leukaemia

Not recruiting

Study Comparing Ibrutinib, Venetoclax, and Obinutuzumab for Untreated Chronic Lymphocytic Leukemia Patients

Registered drugNo placebo
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:Ibrutinib
  • Sponsor:University Of Cologne

Systemic lupus erythematosus

Not recruiting

Study on the Effectiveness and Safety of Afimetoran for Patients with Active Lupus

Investigational
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Sponsor:Beeline Medicines Corp.

Post-traumatic stress disorder

Not recruiting

Study of Methylone Treatment for Adults with Post-Traumatic Stress Disorder (PTSD)

Investigational
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:Methylone
  • Sponsor:Transcend Therapeutics Inc.

Other cities in Ireland

The busiest research cities in the country

All 16 cities in Ireland

Clinical research in Drogheda

What the registry says about research in the country

01 Gastrointestinal Disorders

Innovative research focusing on inflammatory bowel diseases, including trials evaluating new therapeutic approaches for ulcerative colitis and Crohn's disease. Studies are examining novel compounds like obefazimod for improving patient outcomes.

  • Ulcerative Colitis Management
  • Crohn's Disease Treatment
  • Celiac Disease Therapy

Multiple trials are investigating endoscopic improvement and symptomatic remission in patients with moderate to severe conditions.

02 Infectious Disease Prevention

Groundbreaking research in preventing and treating various infections, with particular focus on Clostridioides difficile infection recurrence and surgical site infections following abdominal procedures.

  • Post-Surgical Infection Prevention
  • C. difficile Treatment
  • Anti-infective Therapies

Studies are evaluating novel preventive measures and treatment approaches to reduce infection rates.

03 Dermatological Conditions

Clinical research examining treatments for chronic skin conditions, with emphasis on Hidradenitis Suppurativa. Trials are evaluating new biological therapies like lutikizumab for moderate to severe cases.

  • Inflammatory Skin Diseases
  • Novel Biological Treatments
  • Chronic Condition Management

Research focuses on improving symptoms and quality of life for patients with persistent skin disorders.

Back to IrelandAll countries
Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.